TARGETING OF BRD4 AS A NOVEL THERAPEUTIC CONCEPT IN JAK2 V617F+ MPN

EHA Library, Alexandra Keller, 133276

LNK MUTATIONS IN FAMILIAL MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Elisa Rumi, 133277

HOMOZYGOUS CALRETICULIN MUTATIONS IN PATIENTS WITH MYELOFIBROSIS LEAD TO ACQUIRED MYELOPEROXIDASE DEFICIENCY

EHA Library, Alexandre , 133278

CHARACTERISATION OF THE INFLAMMATORY MICROENVIRONMENT IN MYELOPROLIFERATIVE NEOPLASMS AND ITS FUNCTIONAL IMPACT ON STEM AND PROGENITOR CELLS

EHA Library, Nina Friesgaard Oebro, 133279

MESENCHYMAL STROMAL CELLS (MSC) FROM HIGH-GRADE BONE MARROW FIBROSIS PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS (PH-NEG MPN) DISPLAY REDUCED CLONOGENICITY AND PROLIFERATION CAPACITY.

EHA Library, Benedetta Rambaldi, 133280

NEXT-GENERATION SEQUENCING IDENTIFIES MPL-TET2 MUTATED CLONES IN A SUBSET OF PATIENTS WITH JAK2V617F-POSITIVE MYELOFIBROSIS

EHA Library, Susann Schulze, 133281

THE INNATE AND ADAPTIVE IMMUNE SYSTEM IS SIGNIFICANTLY DYSREGULATED IN MYELOFIBROSIS: EVIDENCE OF A CENTRAL ROLE OF MUTATIONAL STATUS

EHA Library, Lucia Catani, 133282

SAFETY AND EFFICACY OF RUXOLITINIB IN PATIENTS WITH DIPSS INTERMEDIATE-1–RISK MYELOFIBROSIS (MF) FROM JUMP: AN OPEN-LABEL, MULTICENTER, SINGLE-ARM, EXPANDED-ACCESS STUDY

EHA Library, Francesco Passamonti, 133283

PHASE 3 TRIAL TEAM-ET IN 106 HIGH-RISK ESSENTIAL THROMBOCYTHEMIA PATIENTS, DEMONSTRATING NON-INFERIORITY OF ANATHROMB, A NOVEL, EXTENDED-RELEASE ANAGRELIDE FORMULATION, TO THE LICENSED COMPARATOR

EHA Library, Heinz Gisslinger, 133284

CLINICAL IMPACT OF ONCOGENETIC PROFILES IN SYSTEMIC MASTOCYTOSIS WITH AN ASSOCIATED HEMATOLOGICAL NON-MAST CELL DISEASE.

EHA Library, Alberto Orfao, 133285

MUTATIONAL STUDY OF GENES INVOLVED IN MYELOFIBROSIS BY MASSIVE SEQUENCING

EHA Library, Ana Africa Martin Lopez, 133286

PHASE II STUDY OF LCL161, A SMAC MIMETIC, IN PATIENTS WITH PRIMARY MYELOFIBROSIS (PMF), POST-POLYCYTHEMIA VERA MYELOFIBROSIS (POST-PV MF) OR POST-ESSENTIAL THROMBOCYTOSIS MYELOFIBROSIS (POST-ET MF

EHA Library, Naveen Pemmaraju, 133287

PREVENTION OF THROMBOSIS IN PATIENTS WITH POLYCYTHEMIA VERA TREATED WITH HYDROXUYUREA PLUS PHLEBOTOMIES OR HYDROXYUREA ALONE

EHA Library, Alberto Alvarez-Larrán, 133288

RATE OF MALIGNANT TRANSFORMATION IN HIGH RISK ET DURING 5 YEARS OF FOLLOW-UP OF CYTOREDUCTIVE THERAPY

EHA Library, Gunnar Birgegard, 133289

MIDOSTAURIN (PKC412) IN INDOLENT SYSTEMIC MASTOCYTOSIS: A PHASE 2 TRIAL

EHA Library, Bart Span, 133290

RISK FACTORS (RF) FOR RELAPSE IN PATIENTS WITH RELAPSED OR REFRACTORY HODGKIN LYMPHOMA (RRHL) AFTER AUTOLOGOUS STEM CELL TRANSPLANT (ASCT): A REAL-WORLD ANALYSIS IN GERMANY AND THE UNITED KINGDOM (UK)

EHA Library, Erin Zagadailov, 133291

BRENTUXIMAB VEDOTIN (BV) IN PATIENTS WHO ARE INELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANT (ASCT) WITH RELAPSED OR REFRACTORY HODGKIN LYMPHOMA (RRHL): A UK AND GERMANY RETROSPECTIVE STUDY

EHA Library, Paul J Bröckelmann, 133292

REAL-WORLD EFFECTIVENESS OF BRENTUXIMAB VEDOTIN (BV) VS. OTHER TREATMENTS IN PATIENTS WITH RELAPSED/REFRACTORY HODGKIN LYMPHOMA (RRHL) POST AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT)

EHA Library, Erin Zagadailov, 133293

ABDOMEN/PELVIS COMPUTED TOMOGRAPHY IN STAGING OF PEDIATRIC HODGKIN LYMPHOMA: IS IT ALWAYS NECESSARY?

EHA Library, Piero Farruggia, 133294

INCREASED CORONARY ARTERY CALCIUM SCORE AFTER RADIOTHERAPY IN HODGKIN LYMPHOMA SURVIVORS

EHA Library, Elena Van Leeuwen, 133295

THE LYMPHOMA ASSOCIATED MACROPHAGES-HODGKIN/REED-STERNBERG CELLS RATIO IS A POOR PROGNOSTIC FACTOR IN CLASSIC HODGKIN LYMPHOMA PATIENTS

EHA Library, Eva Kriegová, 133296

THE PROGNOSTIC ROLE OF BCL-2 EXPRESSION IN PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA ASSESSED FOR CD68+ CELL COUNT.

EHA Library, Annarosa Cuccaro, 133297

AUTOLOGOUS STEM CELL TRANSPLANTATION (AUTO-SCT) IS HIGHLY EFFECTIVE IN RELAPSED NODULAR LYMPHOCYTE-PREDOMINANT HODGKIN LYMPHOMA (NLPHL): A RETROSPECTIVE STUDY BY THE EBMT LYMPHOMA WORKING PARTY

EHA Library, Anna Sureda, 133298

BIOLOGICALLY MEANINGFUL CHANGES IN CYTOKINE AND CHEMOKINE PRODUCTION FOLLOWING IBRUTINIB THERAPY IN WALDENSTROM’S MACROGLOBULINEMIA.

EHA Library, Josephine Vos, 133299

A PHASE III STUDY OF OFATUMUMAB VS RITUXIMAB IN INDOLENT B-CELL NON-HODGKIN LYMPHOMA RELAPSED AFTER RITUXIMAB-CONTAINING THERAPY (HOMER): RESULTS OF THE INTERIM ANALYSIS

EHA Library, David MALONEY, 133300

A PHASE IB STUDY EVALUATING THE SAFETY AND CLINICAL ACTIVITY OF ATEZOLIZUMAB COMBINED WITH OBINUTUZUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY NON-HODGKIN LYMPHOMA

EHA Library, Melissa Kuhn, 133301

LONG-TERM FOLLOW-UP OF THE NEXT GENERATION PI3K-DELTA INHIBITOR TGR-1202 DEMONSTRATES SAFETY AND HIGH RESPONSE RATES IN NHL: INTEGRATED-ANALYSIS OF TGR-1202 MONOTHERAPY AND COMBINED WITH UBLITUXIMAB.

EHA Library, Owen O'Connor, 133302

THE COMBINATION OF IBRUTINIB AND VENETOCLAX (ABT-199) RAPIDLY ACHIEVES COMPLETE REMISSIONS IN PATIENTS WITH RELAPSED / REFRACTORY MANTLE CELL LYMPHOMA: PRELIMINARY RESULTS OF THE PHASE II AIM STUDY

EHA Library, Constantine S. Tam, 133303

IDELALISIB MONOTHERAPY IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (FL): EXPERIENCE THROUGH AN EARLY ACCESS PROGRAM IN EUROPE AND AUSTRALIA

EHA Library, Andrew J. Davies, 133304

PHASE 2A STUDY OF THE PHOSPHATIDYLINOSITOL-3-KINASE (PI3K) INHIBITOR COPANLISIB IN PATIENTS WITH RELAPSED/REFRACTORY, INDOLENT OR AGGRESSIVE LYMPHOMA

EHA Library, Martin Dreyling, 133305

PRELIMINARY SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF DUVELISIB PLUS RITUXIMAB OR OBINUTUZUMAB IN PATIENTS WITH PREVIOUSLY UNTREATED CD20+ FOLLICULAR LYMPHOMA

EHA Library, Carla Casulo, 133306

SAFETY AND EFFICACY PROFILES OF CLARITHROMYCIN MONOTHERAPY IN 55 PATIENTS WITH EXTRANODAL MARGINAL ZONE LYMPHOMA (EMZL)

EHA Library, Andres Jose Maria Ferreri, 133307

A PHASE I STUDY IN T CELL LYMPHOMA PATIENTS TREATED WITH ANTI-CD70 SIMPLE ANTIBODY™ ARGX-110

EHA Library, Jean-Marie Michot, 133308

TO SCREEN BIOLOGICAL MARKER GENE ASSOCIATED WITH B CELL IN CHRONIC GRAFT-VERSUS-HOST DISEASE (CGVHD) PATIENTS

EHA Library, Limin Liu, 133309

MITOCHONDRIAL INHIBITION BY NICOTINAMIDE RIBOSIDE POTENTLY STIMULATES HEMATOPOIESIS AFTER TRANSPLANTATION VIA THE MITOCHONDRIAL UNFOLDED PROTEIN RESPONSE

EHA Library, Nicola Vannini, 133310

MESENCHYMAL STROMAL CELLS STIMULATE THE PROLIFERATION AND IL-22 PRODUCTION BY TYPE 3 INNATE LYMPHOID CELLS

EHA Library, Mette Hazenberg, 133311

GRANULOCYTE COLONY-STIMULATING FACTOR MOBILIZATION INCREASES THE PROPORTION OF REGULATORY GAMMA DELT T CELLS

EHA Library, Li Xuan, 133312

PREACTIVATED MESENCHYMAL STROMAL CELLS IMPROVE T-CELL REGENERATION AFTER THEIR COTRANSPLANTATION WITH HEMATOPOIETIC STEM CELLS

EHA Library, Selim Kuci, 133313

EVIDENCE OF COMPLEMENT DYSREGULATION IN TRANSPLANT – ASSOCIATED THROMBOTIC MICROANGIOPATHY

EHA Library, Eleni Gavriilaki, 133314

FAMILY-DIRECTED CORD BLOOD BANKING FOR SICKLE CELL DISEASE: A 20-YEAR EXPERIENCE, ON BEHALF OF EUROCORD-MONACORD AND THE INTERNATIONAL SICKLE CELL DISEASE OBSERVATORY.

EHA Library, Hanadi El Ayoubi, 133315

CONSOLIDATION BY ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) IN CR1 AGED 40-69 YEARS: A COMPARISON OF MYELOABLATIVE AND REDUCED INTENSITY CONDITIONING

EHA Library, Aniko Szabo, 133316

RELAPSED/REFRACTORY HIGH GRADE B CELL NON-HODGKIN LYMPHOMA: SHOULD ONGOING PET POSITIVITY PRECLUDE AUTOLOGOUS TRANSPLANTATION IN PATIENTS ATTAINING A CT RESPONSE TO SALVAGE CHEMOTHERAPY?

EHA Library, Nagah Elmusharaf, 133317

MARAVIROC CONCENTRATIONS ARE HIGHLY PREDICTIVE OF ACUTE GRAFT-VERSUS-HOST DISEASE IN REDUCED-INTENSITY ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Alex Ganetsky, 133318

HYPERACUTE GRAFT VERSUS HOST DISEASE: RISK FACTORS, OUTCOMES AND IMPACT OF TACROLIMUS/SIROLIMUS PROPHYLAXIS.

EHA Library, MD Caballero, 133319

REDUCED INTENSITY CONDITIONING TRANSPLANTATION (RIC) AS PART OF FIRST LINE THERAPY FOR MANTLE CELL LYMPHOMA: RESULTS FROM THE PHASE II MINI ALLO TRIAL (CRUK: C7627/A9080)

EHA Library, Simon Rule, 133320

THE ROLL OF HYPOMETHYLATING AGENTS IN MYELOID RELAPSES AFTER ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANT.

EHA Library, Felix Lopez Cadenas, 133321

IMPROVED CLINICAL OUTCOMES OF GBM/GPB MIXTURE HAPLOIDENTICAL TRANSPLANTATION WHEN COMPARED TO A PROPENSITY SCORE-MATCHED GPB HAPLOIDENTICAL TRANSPLANTATION: A MULTICENTER STUDY

EHA Library, Xiaojun Huang, 133322

TREATMENT OF CHRONIC GRAFT VERSUS HOST DISEASE WITH A COMBINATION OF B-CELL DEPLETION AND TYROSINE KINASE INHIBITION

EHA Library, Lotte van der Wagen, 133323

FIRST-LINE EXTRACORPOREAL PHOTOCHEMOTHERAPY (ECP) FOR ACUTE GVHD AFTER ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Lucio Morabito, 133324

EFFICACY OF HOST-DENDRITIC CELL VACCINATIONS WITH AND WITHOUT MINOR HISTOCOMPATIBILITY ANTIGEN LOADING, COMBINED WITH DONOR LYMPHOCYTE INFUSION IN MULTIPLE MYELOMA PATIENTS

EHA Library, Rimke Oostvogels, 133325

TRACING OF URINARY EXCRETION OF BKV AND JCV BY QUANTITATIVE PCR IN RECIPIENTS OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTS (ALLO-HSCT) TO ANTICIPATE THE DEVELOPMENT OF HEMORRHAGIC CYSTITIS (HC).

EHA Library, Ana Pilar González Rodríguez, 133326

OUTCOMES AFTER AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION (SCT) IN DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) PATIENTS WITH MYC/BCL2 CO-EXPRESSION, DOUBLE-HIT LYMPHOMA, OR MYC COPY GAIN

EHA Library, Alex F. Herrera, 133327

BTLA GENOTYPE AND CLINICAL OUTCOME AFTER HLA-IDENTICAL SIBLING STEM CELL TRANSPLANTATION

EHA Library, Nazly Santos, 133328

HIGH-DOSE VERSUS STANDARD-DOSE RITUXIMAB WITH BEAM IN AUTOLOGOUS STEM CELL TRANSPLANTATION (SCT) FOR RELAPSED AGGRESSIVE B-CELL NON-HODGKIN’S LYMPHOMAS (NHL)

EHA Library, Samer Srour, 133329

INTERFERON GAMMA (IFN-GAMMA) NEUTRALIZATION AS A VALUABLE THERAPEUTIC TARGET IN PRIMARY HLH

EHA Library, Franco Locatelli, 133330

BIDIRECTIONAL RELATIONSHIP BETWEEN CMV-R AND AGVHD: CMV-R HAS A BETTER OVERALL SURVIVAL AND T CELL RECONSTITUTION

EHA Library, Pavankumar Varanasi, 133331

HIGH DOSE CHEMOTHERAPY WITH AUTOGRAFT MAY IMPROVE THE POOR PROGNOSIS OF NAIVE DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS WITH MYC/BCL2 CO-EXPRESSION

EHA Library, Anna Guidetti, 133332

BIOMARKERS PREDICTING ACUTE GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS: A PROSPECTIVE STUDY IN 120 PATIENTS

EHA Library, Linda Cheyenne Vaccari, 133333

BONE MARROW WT1 LEVELS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT (HCT) FOR ACUTE MYELOID LEUKEMIA AND MYELODYSPLASIA. STUDY TIME POINTS AND THRESHOLDS WITH CLINICAL RELEVANCE.

EHA Library, Josep Nomdedeu Guinot, 133334

TRANSPLANTATION FROM MATCHED UNRELATED AND HAPLOIDENTICAL DONOR IN PEDIATRIC SEVERE APLASTIC ANEMIA: EXPERIENCE WITH TCR ALPHA/BETA AND CD19 DEPLETION AS GRAFT PROCESSING METHOD.

EHA Library, Andrey Abrosimov, 133335

THE PRC2 COMPONENT JARID2 IS DISPENSABLE FOR HEMATOPOIETIC STEM CELLS BUT CRITICAL FOR THE MAINTENANCE OF LEUKEMIC STEM CELLS

EHA Library, Anne-Katrine Frank, 133336

HHEX PROMOTES HSC SELF-RENEWAL AND STRESS HEMATOPOIESIS VIA REPRESSION OF CDKN2A

EHA Library, Jacob T Jackson, 133337

WNT5A FROM THE NICHE REGULATES THE ACTIN REGULATORY PATHWAY IN HEMATOPOIETIC STEM CELLS

EHA Library, Robert A.J. Oostendorp, 133338

NPM1 IS REQUIRED FOR NORMAL HEMATOPOIESIS

EHA Library, Chow Hiang Ang, 133339

PLZF MUTATION ALTERS MOUSE HEMATOPOIETIC STEM CELL FUNCTION AND CELL CYCLE PROGRESSION

EHA Library, Christelle VINCENT-FABERT, 133340

IL-1 INDUCED ACTIVATION OF QUIESCENT HEMATOPOIETIC STEM CELLS IN VIVO

EHA Library, Uta Demel, 133341

SFRP2 FROM THE NICHE IS REQUIRED TO MAINTAIN THE REGENERATION OF THE HEMATOPOIETIC STEM CELL POOL

EHA Library, Robert A.J. Oostendorp, 133342

CLEC-2 EXPRESSION IS A NEW MARKER FOR A SUBSET OF HEMATOPOIETIC STEM/PROGENITOR CELLS THAT CONTRIBUTES TO INFLAMMATION-INDUCED EMERGENT MEGAKARYOPOIESIS

EHA Library, Takahiro Kumode, 133343

IN VITRO AND IN VIVO STEM CELL PROPERTIES OF HIGHLY ENRICHED HUMAN BONE MARROW MESENCHYMAL STROMAL CELLS

EHA Library, Stefan SCHEDING, 133344

GENOME WIDE DYSREGULATION OF GENE EXPRESSION BY TRISOMY 21 IN FETAL LIVER HAEMATOPOIETIC STEM AND PROGENITOR CELLS

EHA Library, Anindita Roy, 133345

GPR56: A NOVEL MOLECULE INVOLVED IN HEMATOPOIETIC STEM CELL GENERATION

EHA Library, Emma de Pater, 133346

DENDRITIC CELL THERAPY FOR MALIGNANT PLEURAL MESOTHELIOMA (MPM): FINAL RESULTS OF A PHASE I/II CLINICAL TRIAL

EHA Library, Kirsten Saevels, 133347

EXPLORING CHIMERIC NATURAL KILLER RECEPTOR NKP30 EXPRESSING HUMAN T LYMPHOCYTES FOR ADOPTIVE IMMUNOTHERAPY TO ACUTE LEUKEMIA.

EHA Library, Udo Hartwig, 133348

TARGETING CD123+ ACUTE MYELOID LEUKEMIA CELLS WITH REDIRECTED NATURAL KILLER CELLS

EHA Library, Michael Morgan, 133349

CORD BLOOD DERIVED NK CELLS TRANSFER HISTONE H2AZ TO MULTIPLE MYELOMA CELLS CAUSING DIRECT AND INDIRECT CYTOTOXICITY

EHA Library, Lorena Pérez Amill, 133351

ALLOGENEIC TCRA/CD38 DOUBLE KNOCKOUT T-CELLS BEARING AN ANTI-CD38 CHIMERIC ANTIGEN RECEPTOR: AN IMPROVED IMMUNOTHERAPY FOR THE TREATMENT OF T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AND MULTIPLE MYELOMA.

EHA Library, Mathilde Dusseaux, 133352

OPTIMIZED AAV-MEDIATED HUMAN FACTOR VIII GENE THERAPY IN HEMOPHILIA A MICE AND CYNOMOLGUS MACAQUES

EHA Library, Jenny A Greig, 133353

A DOSE-ESCALATING PRECLINICAL STUDY TO DETERMINE THE SAFETY, EFFICACY, AND MINIMUM EFFECTIVE DOSE OF A CLINICAL CANDIDATE VECTOR IN A MOUSE MODEL OF HEMOPHILIA B

EHA Library, Lili Wang, 133354

THE LCR-FREE GAMMA-GLOBIN LENTIVIRAL VECTOR COMBINING TWO HPFH ACTIVATING ELEMENTS CORRECTS MURINE THALASSEMIC PHENOTYPE IN VIVO

EHA Library, Panayotis Antoniou, 133355

BALANCE OF ANTI-CD123 CHIMERIC ANTIGEN RECEPTOR (CAR) BINDING AFFINITY AND DENSITY IN AN IN VITRO MODEL OF ACUTE MYELOID LEUKEMIA

EHA Library, Sarah Tettamanti, 133356

PHARMACOKINETICS (PK) AND PHARMACODYNAMICS (PD) OF GBT440, A NOVEL HEMOGLOBIN S (HBS) POLYMERIZATION INHIBITOR FOR THE TREATMENT OF SICKLE CELL DISEASE (SCD), IN HEALTHY VOLUNTEERS AND SCD PATIENTS

EHA Library, Mira Pochron, 133357

GBT440, A NOVEL HBS POLYMERIZATION INHIBITOR, INCREASES HB OXYGEN AFFINITY AND RESULTS IN A RAPID IMPROVEMENT IN HEMOLYSIS AND ANEMIA

EHA Library, Paul Telfer, 133358

CEREBROVASCULAR RESERVE IN SICKLE CELL DISEASE ASSESSED WITH PERFUSION MAGNETIC RESONANCE IMAGING

EHA Library, Lena Vaclavu, 133359

RESTING STATE FUNCTIONAL MRI SHOWS HOW COGNITIVE PERFORMANCES COULD BE PRESERVED IN CHILDREN WITH SICKLE CELL DISEASE

EHA Library, R Colombatti, 133360

INFLUENCE OF UNDERWEIGHT STATUS ON THE CLINICAL PHENOTYPE OF AN INTERNATIONAL COHORT OF SICKLE CELL DISEASE PATIENTS: THE CASIRE GROUP ANALYSIS

EHA Library, R Colombatti, 133361

IMPROVEMENT IN CARE QUALITY FOLLOWING DEVELOPMENT OF A NEW ADULT SICKLE CELL DISEASE CENTER WITHIN AN ACADEMIC CANCER CENTER

EHA Library, Biree Andemariam, 133362

KLOTHO GENE POLYMORPHISMS AND THEIR ASSOCIATION WITH CLINICAL MANIFESTATIONS IN PATIENTS WITH SICKLE CELL ANEMIA

EHA Library, Anderson Cunha, 133363

ASSOCIATION BETWEEN ENVIRONMENTAL FACTORS AND HOSPITAL ADMISSIONS FOR SICKLE CELL DISEASE: A RETROSPECTIVE TIME SERIES ANALYSIS

EHA Library, Sanjay Tewari, 133364

MULTICENTER, PROSPECTIVE, RANDOMIZED TRIAL OF INTRAVENOUS ITRACONAZOLE VS. LIPOSOMAL AMPHOTERICIN B AS EMPIRICAL ANTIFUNGAL THERAPY FOR HEMATOLOGICAL MALIGNANCY WITH PERSISTENT FEVER AND NEUTROPENIA

EHA Library, Isao Yoshida, 133365

PREVALENCE, STRUCTURE, AND PUTATIVE MECHANISM FOR TEMPLATED INSERTIONS IN VDJ RECOMBINATION

EHA Library, Marvyn Koning, 133366

FLUOROQUINOLONE PROPHYLAXIS SIGNIFICANTLY AFFECTS BACTERIAL EPIDEMIOLOLOGY AND ANTIBIOTIC RESISTANCE BUT DOES NOT IMPACT ON INCIDENCE AND MORTALITY OF BLOODSTREAM INFECTIONS IN ACUTE LEUKAEMIA

EHA Library, Chiara Cattaneo, 133367

VIRAL ENCEPHALITIS AFTER HAPLO-IDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION: CAUSATIVE VIRAL SPECTRUM, CHARACTERISTICS AND RISK FACTORS

EHA Library, Xiaohui Zhang, 133368

COMPREHENSIVE MONITORING OF GUT MICROBIOTA DURING THERAPY FOR ACUTE LEUKEMIA

EHA Library, Mareike Aichholzer, 133369

INVASIVE FUNGAL INFECTIONS IN LYMPHOPROLIFERATIVE DISORDERS: REVISION OF INCIDENCE IN THE “MODERN TREATMENT” ERA

EHA Library, Maria Chiara Tisi, 133370

INFECTIOUS AND THROMBOTIC COMPLICATIONS IN PERIPHERALLY INSERTED (PICCS) COMPARED TO SHORT TERM CENTRAL VENOUS CATHETERS IN ONCOHEMATOLOGIC PATIENTS: A REL GROUP (RETE EMATOLOGICA LOMBARDA) STUDY

EHA Library, Nicola Stefano Fracchiolla, 133371

USEFULNESS OF SERUM 1,3-B-D-GLUCAN FOR DIAGNOSIS OF INVASIVE FUNGAL DISEASE IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES: A RETROSPECTIVE ANALYSIS

EHA Library, Zdenek Racil, 133372

DIFFERENT ISOFORM LOCALIZATION GOVERNS SIGNALING QUALITY OF DECTIN-1 IN THE REGULATION OF ANTI-FUNGAL IMMUNITY

EHA Library, Ulf Schnetzke, 133373

PRELIMINARY REPORT OF FUNGEMIA IN HEMATOLOGICAL MALIGNANCIES FROM SEIFEM-2015 SURVEY

EHA Library, Luana Fianchi, 133374

PROGNOSTIC FACTORS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES ADMITTED TO THE INTENSIVE CARE UNIT: EXPERIENCE WITH 335 PATIENTS FROM A SINGLE CENTER

EHA Library, Alfredo Rivas-Delgado, 133375

SAFETY AND EFFICACY OF HUMAN T-LYMPHOTROPIC VIRUS 1 (HTLV-1) HYPERIMMUNE GLOBULIN AGAINST HTLV-1 INFECTION IN A HUMANIZED MOUSE MODEL.

EHA Library, Takuo Mizukami, 133376